PACIRA BIOSCIENCES, INC. Secured Debt, Current
PACIRA BIOSCIENCES, INC. (PCRX) had Secured Debt, Current of $0 as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:SecuredDebtCurrent · last filed 2024-02-29
- 2023-12-31: Secured Debt, Current $0.00.
- 2023-09-30: Secured Debt, Current $0.00.
- 2023-06-30: Secured Debt, Current $10.86M.
- 2023-03-31: Secured Debt, Current $10.85M.
| Period end | Secured Debt, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $10.86M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $10.85M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $33.65M 10-K · filed 2024-02-29 |
| 2022-09-30 | $33.87M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $33.78M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $33.68M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $24.23M 10-K · filed 2023-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |